Skip to main content
Figure 3 | BMC Anesthesiology

Figure 3

From: Tolerability of NGX-4010, a capsaicin 8% dermal patch, following pretreatment with lidocaine 2.5%/prilocaine 2.5% cream in patients with post-herpetic neuralgia

Figure 3

Dermal irritation. Dermal assessments were carried out to assess dermal irritation on the day of treatment before and immediately after application of lidocaine 2.5%/prilocaine 2.5% cream, at various time points following patch removal up to 85 minutes, and on study Day 7. Results show the percentage of patients at each time point with a dermal assessment score of 0 (no evidence of irritation), 1 (minimal erythema, barely perceptible), or 2 (definite erythema, readily visible; minimal edema, or minimal papular response), which was the maximum score recorded. Due to rounding, some figures do not add up to 100. TA; topical anesthetic.

Back to article page